About the company's completed Phase 3 trial with l
Post# of 148087
If that's correct (and please correct me if I'm wrong), did the drug ever receive approval for that indication or do you have to have a successful Biologics License Application in order to obtain a drug approval from the FDA?
And is there any thought to using a good CRO to refile the BLA, or has the market moved away to another solution for treatment-experienced patients?
Or is there another reason we aren't pursuing that indication when we've already had a successful trial? Maybe it has something to do with the recent macaque rhesus experiments? I did not invest in the company until after the Phase 3 HIV trial, so I don't know this part of the history that well and am thanking you in advance for any enlightenment.
Thanks, Ramjet